Contact Information: Contact: Janet Moore 949-645-2111
Biomerica Announces Sale of Minority Interest in Lancer Orthodontics, Inc.
| Quelle: Biomerica
NEWPORT BEACH, CA--(Marketwire - May 29, 2008) - On May 27, 2008, Biomerica sold its
investment in Lancer Orthodontics, Inc., in a private transaction. Net
proceeds from the sale were $1,083,444. The investment was carried on the
Biomerica balance sheet at date of sale at a value of $464,823 and
therefore results in a realized gain of $618,621.
About Biomerica (OTCBB : BMRA )
Biomerica, Inc. (http://www.biomerica.com) is a global medical technology
company, based in Newport Beach, CA. The Company's diagnostics division
manufactures and markets advanced diagnostic products used at home, in
hospitals, and in physicians' offices for the early detection of
significant medical conditions and serious diseases.
Certain information included in this press release (as well as information
included in oral statements or other written statements made or to be made
by Biomerica) contains statements that are forward-looking; such as
statements relating to intended improvements to the Company's financial
performance, continued growth in business, launch dates, expansion,
expected orders, growth prospects, leading market positions, anticipated
future sales revenues of the company, success of product(s) and new product
introductions. Such forward-looking information involves important risks
and uncertainties that could significantly affect anticipated results in
the future, and accordingly, such results may differ materially from those
expressed in any forward-looking statements made by or on behalf of
Biomerica. The potential risks and uncertainties include, among others,
fluctuations in the Company's operating results due to its new business
model and expansion plans, the Company's ability to raise additional
capital, the competitive environment in which the Company will be
competing, and the Company's dependence on strategic relationships. The
Company is under no obligation to update any forward-looking statements
after the date of this release.